177 related articles for article (PubMed ID: 34846005)
1. Design and development of an e-nose system for the diagnosis of pulmonary diseases.
Binson VA; Subramoniam M
Acta Bioeng Biomech; 2021; 23(1):35-44. PubMed ID: 34846005
[TBL] [Abstract][Full Text] [Related]
2. Detection of COPD and Lung Cancer with electronic nose using ensemble learning methods.
V A B; Subramoniam M; Mathew L
Clin Chim Acta; 2021 Dec; 523():231-238. PubMed ID: 34627826
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose.
V A B; Subramoniam M; Mathew L
Expert Rev Mol Diagn; 2021 Nov; 21(11):1223-1233. PubMed ID: 34415806
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of COPD and lung cancer from controls through breath analysis using a self-developed e-nose.
Binson VA; Subramoniam M; Mathew L
J Breath Res; 2021 Aug; 15(4):. PubMed ID: 34243176
[TBL] [Abstract][Full Text] [Related]
5. Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis.
Tirzīte M; Bukovskis M; Strazda G; Jurka N; Taivans I
J Breath Res; 2017 Aug; 11(3):036009. PubMed ID: 28585921
[TBL] [Abstract][Full Text] [Related]
6. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
7. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
8. A Metal Oxide Gas Sensors Array for Lung Cancer Diagnosis Through Exhaled Breath Analysis.
Marzorati D; Mainardi L; Sedda G; Gasparri R; Spaggiari L; Cerveri P
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1584-1587. PubMed ID: 31946198
[TBL] [Abstract][Full Text] [Related]
9. Recognizing lung cancer and stages using a self-developed electronic nose system.
Chen K; Liu L; Nie B; Lu B; Fu L; He Z; Li W; Pi X; Liu H
Comput Biol Med; 2021 Apr; 131():104294. PubMed ID: 33647830
[TBL] [Abstract][Full Text] [Related]
10. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
[TBL] [Abstract][Full Text] [Related]
12. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
[TBL] [Abstract][Full Text] [Related]
13. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
14. The Role of Electronic Noses in Phenotyping Patients with Chronic Obstructive Pulmonary Disease.
Scarlata S; Finamore P; Meszaros M; Dragonieri S; Bikov A
Biosensors (Basel); 2020 Nov; 10(11):. PubMed ID: 33187142
[TBL] [Abstract][Full Text] [Related]
15. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
16. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
17. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
[TBL] [Abstract][Full Text] [Related]
19. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
20. Electronic Nose Technology in Respiratory Diseases.
Dragonieri S; Pennazza G; Carratu P; Resta O
Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
